Status:
COMPLETED
Kinetics and Metabolism of Nicotinamide Provided as a Dietary Supplementation
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Respiratory Infection (for Example, Pneumonia, Bronchitis)
Respiratory Infection Virus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The diet of patients with reduced tryptophan serum levels that are either hospitalized for acute respiratory infection or treated for chronic inflammatory diseases such as inflammatory bowel diseases ...
Eligibility Criteria
Inclusion
- Serum tryptophan levels below normal range.
- Acute, infectious respiratory disease requiring treatment (e.g. proven acute SARS-CoV-2 or influenza virus infection with inpatient treatment) or chronic inflammatory disease (e.g. chronic inflammatory bowel disease) in remission or in acute relapse (outpatient or inpatient treatment).
Exclusion
- Inability to give informed consent.
- Pregnancy or breastfeeding.
- Serious other illness, e.g. cancer.
- Anemia: Hb \<10 mg/dL.
- Intake of medication to raise the pH value in the stomach (e.g. proton pump inhibitors, H2 receptor antagonists or antacids) in higher doses over a longer period of time.
Key Trial Info
Start Date :
April 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT07156929
Start Date
April 20 2024
End Date
June 30 2025
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Schleswig-Holstein, Campus Kiel
Kiel, Schleswig-Holstein, Germany, 24105